Cintas Work in process increased by 8.9% to $46.50M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 3.0%, from $45.14M to $46.50M. Over 4 years (FY 2021 to FY 2025), Work in process shows an upward trend with a 3.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $30.68M | $35.33M | $33.86M | $34.28M | $34.31M | $48.25M | $59.34M | $56.38M | $49.02M | $46.06M | $41.44M | $48.46M | $47.54M | $43.74M | $45.14M | $42.62M | $39.32M | $42.69M | $46.50M |
| QoQ Change | — | +15.1% | -4.2% | +1.2% | +0.1% | +40.6% | +23.0% | -5.0% | -13.1% | -6.0% | -10.0% | +16.9% | -1.9% | -8.0% | +3.2% | -5.6% | -7.7% | +8.6% | +8.9% |
| YoY Change | — | — | — | — | +11.8% | +36.6% | +75.3% | +64.5% | +42.9% | -4.5% | -30.2% | -14.1% | -3.0% | -5.1% | +8.9% | -12.1% | -17.3% | -2.4% | +3.0% |
| % of Inventories | 6.6% | 7.6% | 7.0% | 7.3% | 7.2% | 9.4% | 11.2% | 11.1% | 9.8% | 9.7% | 9.2% | 11.8% | 11.9% | 11.1% | 10.7% | 9.5% | 8.7% | 9.5% | 10.3% |
| Share Change | — | +1.0pp | -0.6pp | +0.3pp | -0.0pp | +2.1pp | +1.8pp | -0.0pp | -1.3pp | -0.1pp | -0.5pp | +2.6pp | +0.1pp | -0.8pp | -0.4pp | -1.2pp | -0.8pp | +0.8pp | +0.8pp |